Brain HealthMicroglial Senescence in Alzheimer's: What Natural Products Have and Haven't Shown
Microglia are the brain's resident immune cells, and some researchers think they become senescent, or stuck in a damaged, inflammatory state, with age, possibly feeding Alzheimer's disease. This review argues that identifying true senescence in microglia is harder than it looks, because activation, enlarged lysosomes, lipid buildup and misshapen cells do not prove it on their own. Lab, genetic and human stem-cell studies link mitochondrial protein stress, poor autophagy, DNA damage and chronic inflammatory signaling to senescence-like microglia. Natural compounds such as delphinidin, andrographolide, resveratrol, honokiol, rosmarinic acid and cycloastragenol lower senescence-associated readouts in some experimental systems. But the evidence mainly supports prevention or phenotype modulation, not selective clearance, lasting reversal or improved cognition. Small uncontrolled senolytic trials show treatment is feasible but not that it works. The author calls for better state identification, delayed treatment, and drug exposure measured in the brain. This summary is based on the abstract only.